ENTA: Enanta Pharmaceuticals, Inc. Stock

by  •  • Comments Off on ENTA: Enanta Pharmaceuticals, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 159.52
Enterprise Value ($M) 255.86
Book Value ($M) 93.54
Book Value / Share 4.38
Price / Book 1.70
NCAV ($M) 13.40
NCAV / Share 0.63
Price / NCAV 11.90

Profitability (mra)
Return on Invested Capital (ROIC) -0.31
Return on Assets (ROA) -0.23
Return on Equity (ROE) -0.58

Liquidity (mrq)
Quick Ratio 5.29
Current Ratio 5.29

Balance Sheet (mrq) ($M)
Current Assets 242.86
Assets 322.99
Liabilities 229.46
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 67.64
Operating Income -121.69
Net Income -116.05
Earnings Per Share Diluted n/a
Earnings Per Share Basic n/a

Cash Flow Statement (mra) ($M)
Cash From Operations -78.76
Cash from Investing 58.23
Cash from Financing -27.63

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-17 13G/A BlackRock, Inc. 7.80 -13.50
02-14 13D/A Luly Jay R. 7.70 24.69
02-11 13G/A Farallon Capital Partners, L.P. 9.90 4.11
01-22 13G Integrated Core Strategies (us) Llc 6.50
11-14 13G/A Armistice Capital, Llc 4.72 -51.55
10-17 13G/A Millennium Management Llc 3.50 -44.39

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2025-05-14 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2025-02-12 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q
2024-11-27 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K
2024-08-07 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2025-06-06 20,872 109,426 19.07
2025-06-05 27,294 85,586 31.89
2025-06-04 34,153 129,330 26.41
2025-06-03 77,097 327,986 23.51
2025-06-02 24,774 111,989 22.12

(click for more detail)

Similar Companies
DVAX – Dynavax Technologies Corporation EDIT – Editas Medicine, Inc.
ELVN – Enliven Therapeutics, Inc. ERAS – Erasca, Inc.
EWTX – Edgewise Therapeutics, Inc.


Financial data and stock pages provided by
Fintel.io